This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Should SPDR S&P 400 Mid Cap Growth ETF (MDYG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDYG
Should Invesco S&P MidCap Quality ETF (XMHQ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for XMHQ
Should SPDR Portfolio S&P 400 Mid Cap ETF (SPMD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPMD
Here's Why You Should Hold Carlisle Stock in Your Portfolio Now
by Zacks Equity Research
CSL benefits from strength across its business, acquisitions and shareholder-friendly policies. Rising costs and expenses may hurt its profitability.
Should iShares Core S&P Mid-Cap ETF (IJH) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJH
Here's How Much a $1000 Investment in Carlisle Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Should Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOG
Carlisle (CSL) Up 0.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Carlisle (CSL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Vanguard S&P Mid-Cap 400 ETF (IVOO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOO
Carlisle (CSL) Gains From Business Strength Amid Headwinds
by Zacks Equity Research
Carlisle (CSL) benefits from business strength, acquired assets and shareholder-friendly policies. However, rising costs and high debt levels are concerning.
Is SPDR S&P Homebuilders ETF (XHB) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHB
Should iShares S&P Mid-Cap 400 Growth ETF (IJK) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJK
Are Conglomerates Stocks Lagging Carlisle Companies (CSL) This Year?
by Zacks Equity Research
Here is how Carlisle (CSL) and 3M (MMM) have performed compared to their sector so far this year.
Should You Invest in the SPDR S&P Homebuilders ETF (XHB)?
by Zacks Equity Research
Sector ETF report for XHB
ITT Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
ITT's Q2 revenues increase 8.6% year over year, driven by higher friction original equipment volumes in the Motion Technologies unit and volume growth in aerospace and defense components.
Should JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (BBMC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for BBMC
Should SPDR S&P MidCap 400 ETF (MDY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MDY
3M (MMM) Q2 Earnings & Revenues Surpass Estimates, Rise Y/Y
by Zacks Equity Research
3M (MMM) reports y/y adjusted revenue growth of 1.1% in second-quarter 2024 results.
Carlisle (CSL) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Carlisle's (CSL) second-quarter 2024 results benefit from higher revenues across its segments.
Carlisle (CSL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Carlisle (CSL) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Carlisle (CSL) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Carlisle (CSL) delivered earnings and revenue surprises of 6.85% and 1.51%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
3 Reasons Growth Investors Will Love Carlisle (CSL)
by Zacks Equity Research
Carlisle (CSL) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why Carlisle (CSL) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y
by Zacks Equity Research
Danaher's (DHR) second-quarter earnings and revenues surpass estimates. However, the company's performance reflects a decrease in core sales in the Biotechnology segment.
GE Aerospace (GE) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
GE Aerospace's (GE) second-quarter 2024 results reflect a 4% increase in revenues, driven by the solid performance of its segments.